A revenue-generating, small-cap Canadian pharmaceutical company

Revenue Projected at $150,000,000 by 2025

Free
Message: AGORACOM Small Cap 60: Valeo Pharma (VPH: CSE) (VPHIF: OTCQB) Experiencing Month Over Month Prescription Growth For Asthma Drugs

AGORACOM Small Cap 60: Valeo Pharma (VPH: CSE) (VPHIF: OTCQB) Experiencing Month Over Month Prescription Growth For Asthma Drugs

posted on Mar 21, 2022 11:20AM

Share
New Message
Please login to post a reply